v3.26.1
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]    
Revenue $ 980,778 $ 1,068,303
Cost of Sales (705,668) (777,529)
Gross Profit 275,110 290,774
Operating Expenses (2,927,550) (4,222,892)
Operating Loss (2,652,440) (3,932,118)
Other Income (Expense) (2,602,843) (5,529,826)
Net Loss Before Income Tax (5,255,283) (9,461,944)
Real Estate Segment[Member]    
Segment Reporting [Line Items]    
Revenue 726,659 717,805
Cost of Sales (638,041) (602,785)
Gross Profit 88,618 115,020
Operating Expenses (668,431) (1,144,805)
Operating Loss (579,813) (1,029,785)
Other Income (Expense) 10,720
Net Loss Before Income Tax (579,813) (1,019,065)
Digital Transformation Technology [Member]    
Segment Reporting [Line Items]    
Revenue
Cost of Sales
Gross Profit
Operating Expenses (49,389) (163,554)
Operating Loss (49,389) (163,554)
Other Income (Expense) (57,691) (1,251,283)
Net Loss Before Income Tax (107,080) (1,414,837)
Biohealth Business [Member]    
Segment Reporting [Line Items]    
Revenue
Cost of Sales
Gross Profit
Operating Expenses (97,620) (512,932)
Operating Loss (97,620) (512,932)
Other Income (Expense) (6,262) (698,374)
Net Loss Before Income Tax (103,882) (1,211,306)
Other [Member]    
Segment Reporting [Line Items]    
Revenue 254,119 350,498
Cost of Sales (67,627) (174,744)
Gross Profit 186,492 175,754
Operating Expenses (2,112,111) (2,401,601)
Operating Loss (1,925,619) (2,225,847)
Other Income (Expense) (2,538,890) (3,590,890)
Net Loss Before Income Tax $ (4,464,509) $ (5,816,737)